Home › Funds › Vivo Capital, LLC › BOLT

Vivo Capital, LLC position in BOLT

Bolt Biotherapeutics Inc · Health Care

Vivo Capital, LLC reported holding 72,414 shares of BOLT (Bolt Biotherapeutics Inc) in its Q3 2026 13F filing — a position valued at US$266K, representing 0.03% of its reported portfolio and ranking #46 among its reported holdings. Vivo Capital, LLC has disclosed BOLT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)72.41K sh
Reported value held$266.48K
Portfolio Weight0.03%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's BOLT position evolved

Vivo Capital, LLC first disclosed a stake in BOLT in Q3 2023 at 3,871,291 shares (US$4.0M). The position peaked in Q1 2024 at 3,521,291 shares, worth US$4.9M. Across 13 filings, Vivo Capital, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 72,414 shares valued at US$266K. Notable position changes include a 95% trim in Q2 2025 (shares fell 8% over the following quarter), a 59% trim in Q4 2025 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.87M $4.03M New
Q4 2023 3.52M $3.94M Reduce
Q1 2024 3.52M $4.93M Hold
Q2 2024 3.52M $2.64M Hold
Q3 2024 3.52M $2.28M Hold
Q4 2024 3.52M $1.88M Hold
Q1 2025 3.52M $1.41M Hold
Q2 2025 176.06K $985.96K Reduce
Q3 2025 176.06K $936.66K Hold
Q4 2025 72.41K $395.96K Reduce
Q1 2026 72.41K $292.55K Hold
Q2 2026 72.41K $278.79K Hold
Q3 2026 72.41K $266.48K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BOLT and 13F data

BOLT (Bolt Biotherapeutics Inc) is a Health Care company. 16 other funds we track also report a position in BOLT — the largest reported positions include Board of Trustees of The Leland Stanford Junior University (US$139K), Lynx1 Capital Management LP (US$119K), PFIZER INC (US$112K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BOLT

All BOLT fund holders →

FAQ

How long has Vivo Capital, LLC held BOLT?

Vivo Capital, LLC has disclosed BOLT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Vivo Capital, LLC's current position in BOLT?

As of Q3 2026, Vivo Capital, LLC holds 72.41K shares of BOLT (Bolt Biotherapeutics Inc), valued at $266.48K, representing 0.03% of its reported portfolio and ranking #46.

Has Vivo Capital, LLC been buying or selling BOLT?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC held unchanged its position in BOLT. The position peaked in Q1 2024 at 3.52M shares.

Which other funds hold BOLT?

Other major institutional holders of BOLT include Board of Trustees of The Leland Stanford Junior University, Lynx1 Capital Management LP, PFIZER INC, among 16 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.